Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GraniteShares 2x Long COIN Daily ETF (CONL) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance

GraniteShares 2x Long COIN Daily ETFTrade
Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

GraniteShares 2x Long COIN Daily ETF vs Citius Pharmaceuticals Inc — how do they compare? GraniteShares 2x Long COIN Daily ETF trades at $4.15, while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Citius Pharmaceuticals Inc is trading nearer its 52-week high, GraniteShares 2x Long COIN Daily ETF nearer its low. Which is the better fit depends on your goals.

CONLCTXR
Sector
Leveraged / InverseHealth
52-Week High
$48.70$1.82
52-Week Low
$3.93$0.48
Market Cap
$20.01M
Enterprise Value
$16.23M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GraniteShares 2x Long COIN Daily ETF

CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.

Read more on CONL

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR